{"organizations": [], "uuid": "38efd307259b295564068b3f96dc7e0eb8fe487f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.prnewswire.com", "main_image": "http://content.prnewswire.com/designimages/logo-prn-01_PRN.gif", "site_section": "http://rss.prnewswire.com/industry/entertainment/", "section_title": "PR Newswire: Entertainment & Media", "url": "http://www.prnewswire.com/news-releases/global-joint-venture-partnerships-in-pharma-biotech-and-diagnostics-2010-2015---reportlinker-review-300165044.html", "country": "IT", "title": "Global Joint Venture Partnerships in Pharma, Biotech and Di", "performance_score": 0, "site": "prnewswire.com", "participants_count": 1, "title_full": "Global Joint Venture Partnerships in Pharma, Biotech and Di", "spam_score": 0.0, "site_type": "news", "published": "2015-10-23T00:12:00.000+03:00", "replies_count": 0, "uuid": "38efd307259b295564068b3f96dc7e0eb8fe487f"}, "author": "Reportlinker", "url": "http://www.prnewswire.com/news-releases/global-joint-venture-partnerships-in-pharma-biotech-and-diagnostics-2010-2015---reportlinker-review-300165044.html", "ord_in_thread": 0, "title": "Global Joint Venture Partnerships in Pharma, Biotech and Di", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "NEW YORK , Oct. 22,   The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.\n\nThis second edition, includes: \n\nTrends in joint venture deals\nJoint venture agreement structure\nJoint venture contract documents\nTop joint venture deals by value\nMost active joint venture dealmakers\nComprehensive directory of joint venture deals since 2010\n\nThis report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.\n\nThe report provides details of joint venture agreements from 2010 to end of April 2015 .\n\nThe report provides a detailed understanding and analysis of how and why companies enter joint venture deals. \n\nUnderstanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered â€“ contract documents provide this insight where press releases and databases do not.\n\nThis report contains a comprehensive listing of all joint venture deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.\n\nContract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.\n\nReport scope \n\nGlobal Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 report is intended to provide the reader with an in-depth understanding of the joint venture trends and structure of deals entered into by leading biopharma companies worldwide.\n\nGlobal Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 includes: \n\nTrends in joint venture dealmaking in the biopharma industry since 2010\nAnalysis of joint venture deal structure\nCase studies of real-life joint venture deals\nAccess to over 450 joint venture deal records\nDetailed access to actual joint venture contract documents\nThe leading joint venture deals by value since 2010\nMost active joint venture dealmakers since 2010\nThe leading joint venture partnering resources\n\nIn Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010- 2015, the available contracts are listed by:\n\nCompany A-Z\nHeadline value\nStage of development at signing\nTherapeutic area\nTechnology area\n\nEach deal title links via Weblink to an online version of deal record as found in the Current Agreements deals and alliances database, providing easy access to each deal record on demand.\n\nThe Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010- 2015 report provides comprehensive access to records for over 450 joint venture deals. Analyzing actual contract agreements allows assessment of the following:\n\nWhat are the precise joint venture rights granted or optioned?\nWhat is actually granted by the agreement to the partner company?\nWhat exclusivity is granted?\nWhat is the payment structure for the deal?\nHow aresalesand payments audited?\nWhat is the deal term?\nHow are the key terms of the agreement defined?\nHow are IPRs handled and owned?\nWho is responsible for commercialization?\nWho is responsible for development, supply, and manufacture?\nHow is confidentiality and publication managed?\nHow are disputes to be resolved?\nUnder what conditions can the deal be terminated?\nWhat happens when there is a change of ownership?\nWhat sublicensing and subcontracting provisions have been agreed?\nWhich boilerplate clauses does the company insist upon?\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?\nWhich jurisdiction does the company insist upon for agreement lawGlobal Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 provides the reader with the following key benefits:\nIn-depth understanding of joint venture deal trends since 2010\nAnalysis of the structure of joint venture agreements with numerous real life case studies\nComprehensive access to over 450 joint venture deals entered into by the world's biopharma companies, together with contract documents if available\nDetailed access to actual joint venture contracts entered into by the leading fifty big pharma and big biotech companies\nUnderstand the key deal terms companies have agreed in previous deals\nUndertake due diligence to assess suitability of your proposed deal terms for partner companies\nIdentify leading joint venture deals by value since 2010\nIdentify the most active joint venture dealmakers since 2010\nFull listing of joint venture deals by company A-Z, headline value, phase of development, deal type, therapy and technology focus\nRead the full report: http://www.reportlinker.com/p03095643-summary/view-report.html \n\nAbout Reportlinker \nReportLinker is an award-winning market research solution. Reportlinker reviews, finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.\n\nhttp://www.reportlinker.com", "external_links": [], "published": "2015-10-23T00:12:00.000+03:00", "crawled": "2015-10-23T00:15:31.350+03:00", "highlightTitle": ""}